This webinar is designed to equip healthcare teams with essential information on FDA-approved monthly and weekly injectable buprenorphine formulations for the treatment of opioid use disorder, along with guidance on integrating them into clinical practice. Key topics will include the pharmacology, side effects, and storage of injectable buprenorphine, as well as the administration process, patient selection criteria, and dosage recommendations. The session will also cover the initiation and maintenance of treatment for patients using these injectable formulations, along with the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN: Overdose Prevention Engagement Network. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
